The candidate will be jointly supervised by Prof Piergiuseppe Pelicci and Dr Luca Mazzarella to explore molecular mechanisms of acute myeloid leukemias (AML).
The lab is extensively exploring the interaction between systemic metabolism (modulated by obesity, caloric restriction, intermittent fasting), chromatin dynamics and the regulation of protein quality control (ER stress, UPR) in mouse models of AML, a research project stemming from clinical observations (Breccia, Mazzarella et al Blood 2012).
In particular, we have intensively investigated the biology of the FLT3 kinase, the most commonly mutated gene in AML. We have found that the most frequent genetic alterations involving FLT3 perturb the phyisological folding, maturation and intracellular localization of the protein. This causes global alterations in cellular metabolism which may be favoured by specific dietary components, and creates vulnerabilities that could be targeted pharmacologically.
The candidate will be asked to pursue a research program aimed at exploring the biology of mutant FLT3 using a combination of imaging, transcriptomics, proteomics and metabolomics techniques.
The candidate will join a growing and stimulating research environment at the interface between the clinics and the lab, in a research institute of excellence with state-of-the-art equipment for
Requirements:
For further info or to arrange an informal interview, please write to
luca.mazzarella@ieo.it